Ajay Nooka

Ajay Nooka

UNVERIFIED PROFILE

Are you Ajay Nooka?   Register this Author

Register author
Ajay Nooka

Ajay Nooka

Publications by authors named "Ajay Nooka"

Are you Ajay Nooka?   Register this Author

81Publications

2240Reads

34Profile Views

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.

Cancer 2019 Sep 15;125(17):2991-3000. Epub 2019 May 15.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32178DOI Listing
September 2019

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

N Engl J Med 2019 08;381(8):727-738

From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1903455
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1903455DOI Listing
August 2019

Daratumumab in multiple myeloma.

Cancer 2019 Jul 5;125(14):2364-2382. Epub 2019 Apr 5.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32065DOI Listing
July 2019

Registering a CD38 antibody upfront for multiple myeloma.

Lancet 2019 07 3;394(10192):3-4. Epub 2019 Jun 3.

Winship Cancer Institute of Emory University, Atlanta, GA 30307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31250-4DOI Listing
July 2019

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Leukemia 2019 05 24;33(5):1291-1296. Epub 2019 Jan 24.

Department of Hematology and Medical Oncology, Emory University School of Medicine and the Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0374-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891824PMC
May 2019

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09555-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478743PMC
April 2019

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.

Cancer 2019 02 17;125(3):416-423. Epub 2018 Oct 17.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31718
Publisher Site
http://dx.doi.org/10.1002/cncr.31718DOI Listing
February 2019

Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma.

Cancer J 2019 Jan/Feb;25(1):19-31

From the Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000354DOI Listing
January 2019

Daratumumab and its use in the treatment of relapsed and/or refractory multiple myeloma.

Future Oncol 2018 Dec 23;14(30):3111-3121. Epub 2018 Aug 23.

Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0275DOI Listing
December 2018

Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites.

Cancer 2018 11 10;124(22):4358-4365. Epub 2018 Oct 10.

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31746
Publisher Site
http://dx.doi.org/10.1002/cncr.31746DOI Listing
November 2018

Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma.

J Oncol Pract 2018 09 13;14(9):561-564. Epub 2018 Jul 13.

Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00208DOI Listing
September 2018

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

J Clin Oncol 2018 03 30;36(9):859-866. Epub 2018 Jan 30.

Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5207DOI Listing
March 2018

CD86 regulates myeloma cell survival.

Blood Adv 2017 Nov 16;1(25):2307-2319. Epub 2017 Nov 16.

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017011601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729629PMC
November 2017

Development of GLUT4-selective antagonists for multiple myeloma therapy.

Eur J Med Chem 2017 Oct 14;139:573-586. Epub 2017 Aug 14.

Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2017.08.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603412PMC
October 2017

TG02 inhibits proteasome inhibitor-induced HSF1 serine 326 phosphorylation and heat shock response in multiple myeloma.

Blood Adv 2017 Sep 26;1(21):1848-1853. Epub 2017 Sep 26.

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University and the Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017006122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728095PMC
September 2017

High-risk Multiple Myeloma: Definition and Management.

Clin Lymphoma Myeloma Leuk 2017 07;17S:S80-S87

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.02.018DOI Listing
July 2017

Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.

Infect Control Hosp Epidemiol 2017 06 23;38(6):651-657. Epub 2017 Mar 23.

3Winship Cancer Institute,Emory University,Atlanta,Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2017.12DOI Listing
June 2017

New Targets and New Agents in High-Risk Multiple Myeloma.

Am Soc Clin Oncol Educ Book 2016 ;35:e431-41

From the Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159516DOI Listing
January 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524541PMC
December 2016

Novel combination approaches for myeloma.

Hematology Am Soc Hematol Educ Program 2015 ;2015:286-93

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.286DOI Listing
October 2016

Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation.

Oncotarget 2016 Sep;7(37):59727-59741

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University and the Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10847DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312344PMC
September 2016

Is Maintenance Therapy for Everyone?

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S139-44

Division of Bone Marrow Transplant, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.011DOI Listing
August 2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Aug;375(8):754-66

From the Department of Hematology, University of Turin, Turin, Italy (A.P.); the Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville (A.C.-K.); Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen (K.W.), and University Medical Center of the Johannes Gutenberg-University, Third Department of Medicine, Mainz (M.M.) - both in Germany; Winship Cancer Institute, Emory University, Atlanta (A.K.N.); the Department of Hematology and Stem Cell Transplantation, St. László Hospital, Semmelweis University, Budapest, Hungary (T.M.); Ankara University, Department of Hematology, Ankara, Turkey (M.B.); Clinical Department of Hematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic (I.S.); Irmandade Da Santa Casa De Misericordia De São Paulo, São Paulo (V.H.); University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain (M.V.M.); Weill Cornell Medical College, New York (T.M.M.); Janssen Research and Development, Spring House, PA (M.Q., X.Q., T.A.); Janssen Research and Development, Raritan, NJ (J.S., H.A.); Janssen Research and Development, Beerse, Belgium (W.D.); Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia (A.S.); and the Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606038DOI Listing
August 2016

Death by a thousand cuts: the slow demise of chemotherapy.

Cancer 2016 07 18;122(13):1971-3. Epub 2016 May 18.

Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30024DOI Listing
July 2016

Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.

Cancer Biol Ther 2016 07;17(7):769-77

b Department of Hematology and Medical Oncology , Winship Cancer Institute of Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2016.1192086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970534PMC
July 2016

Novel Combination Treatments in Multiple Myeloma.

Oncology (Williston Park) 2016 May;30(5):451-65

View Article

Download full-text PDF

Source
May 2016

Myeloma Is Not a Single Disease.

J Oncol Pract 2016 Apr;12(4):287-92

Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2016.010926
Publisher Site
http://dx.doi.org/10.1200/JOP.2016.010926DOI Listing
April 2016

Meningeal Myelomatosis.

J Oncol Pract 2016 Feb;12(2):187-8

Winship Cancer Institute of Emory University, Atlanta, GA; and Allegheny Health Network, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.010009DOI Listing
February 2016

Treatment options for relapsed and refractory multiple myeloma.

Blood 2015 May 2;125(20):3085-99. Epub 2015 Apr 2.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA; and.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-11-56
Publisher Site
http://dx.doi.org/10.1182/blood-2014-11-568923DOI Listing
May 2015

Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients.

Cancer 2015 Mar 6;121(6):853-62. Epub 2014 Nov 6.

Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29136DOI Listing
March 2015

From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases.

Biomed Res Int 2013 19;2013:929842. Epub 2013 Nov 19.

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/bmri/2013/929842/
Publisher Site
http://dx.doi.org/10.1155/2013/929842DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852726PMC
August 2014

Incidence and geographic distribution of adult acute leukemia in the state of Georgia.

South Med J 2014 Aug;107(8):497-500

From the Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, the Emory University Rollins School of Public Health, Atlanta, Georgia, and the University of Washington, Fred Hutchinson Cancer Research Center, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14423/SMJ.0000000000000146DOI Listing
August 2014

Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.

Clin Lymphoma Myeloma Leuk 2014 Apr 15;14(2):e59-63. Epub 2013 Nov 15.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650130047
Publisher Site
http://dx.doi.org/10.1016/j.clml.2013.11.007DOI Listing
April 2014

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Oncology 2013 19;85(4):197-203. Epub 2013 Sep 19.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Tex., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000354698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913463PMC
January 2014

Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.

Cancer 2013 Dec 4;119(23):4119-28. Epub 2013 Sep 4.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28325DOI Listing
December 2013

Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.

Biol Blood Marrow Transplant 2013 Sep 10;19(9):1393-5. Epub 2013 Jun 10.

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.06.003DOI Listing
September 2013

Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib.

Biologics 2013 30;7:13-32. Epub 2013 Jan 30.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BTT.S24580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563316PMC
February 2013

Sequential or combination therapy for multiple myeloma.

Expert Rev Hematol 2012 Oct;5(5):533-45

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.49DOI Listing
October 2012

Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease.

Curr Drug Deliv 2012 Jan;9(1):41-51

Moores Cancer Center, University of California, San Diego, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720112798376005DOI Listing
January 2012

Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.

Clin Lymphoma Myeloma Leuk 2011 Dec 1;11(6):498-506. Epub 2011 Sep 1.

Winship Cancer Institute-Hematology and Medical Oncology, Emory University-School of Medicine, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S215226501100236
Publisher Site
http://dx.doi.org/10.1016/j.clml.2011.07.002DOI Listing
December 2011

Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature.

Clin Lymphoma Myeloma Leuk 2011 Oct 12;11(5):379-84. Epub 2011 May 12.

Winship Cancer Institute-Hematology and Medical Oncology, Emory University-School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S215226501100054
Publisher Site
http://dx.doi.org/10.1016/j.clml.2011.04.005DOI Listing
October 2011

Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report.

J Med Case Rep 2011 Aug 12;5:372. Epub 2011 Aug 12.

Winship Cancer Institute, Emory University School of Medicine, 365B Clifton Road NE, Room B5119, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-5-372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169495PMC
August 2011

Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.

Cancer 2011 Jun 22;117(11):2530-40. Epub 2010 Dec 22.

Winship Cancer Institute-Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25765DOI Listing
June 2011

The importance of complete response in outcomes in myeloma.

Cancer J 2009 Nov-Dec;15(6):465-72

Winship Cancer Institute, Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-200911000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e3181c51cd4DOI Listing
January 2011

Improving induction therapy in multiple myeloma.

Curr Hematol Malig Rep 2010 Jul;5(3):119-28

Emory University, Building C, Room 4004, 1365 Clifton Road, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-010-0057-7DOI Listing
July 2010

Supportive therapies in multiple myeloma.

J Natl Compr Canc Netw 2009 Oct;7(9):971-9

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2009.0064DOI Listing
October 2009

Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.

Cancer 2007 Aug;110(3):534-42

Department of Gastrointestinal Medical Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22774DOI Listing
August 2007

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.

Am J Gastroenterol 2007 May 23;102(5):1016-21. Epub 2007 Feb 23.

The Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2007.01104.xDOI Listing
May 2007

Bilateral adrenal hemorrhage: an overlooked cause of hypotension.

J Emerg Med 2007 Feb 22;32(2):167-9. Epub 2007 Jan 22.

Division of Endocrinology, Diabetes and Metabolism, The University of Texas--Houston Medical School, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2006.05.046DOI Listing
February 2007

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.

Cancer 2005 Feb;103(4):749-55

Cancer Research and Treatment Center, The University of New Mexico, Albuquerque, New Mexico 87131, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20821DOI Listing
February 2005

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

Cancer 2004 Aug;101(3):578-86

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20368DOI Listing
August 2004